Citi analyst David Lebowitz initiated coverage of Viking Therapeutics (VKTX) with a Neutral rating and $38 price target Viking’s VK2735 is an “intriguing potential blockbuster,” with its GLP ...

In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Protagonist Therapeutics (PTGX – Research Report). The company’s shares closed yesterday at ...

DALLAS, Feb. 6, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing ...

The three drug discovery deals are with Convelo Therapeutics in neurological disorders such as multiple sclerosis, Sosei Heptares for G-protein-coupled receptor-targeting compounds, and Skyhawk ...

Another company working on an RNA splicing modifier drug for Huntington's is Skyhawk Therapeutics, which reported phase 1 data with its SKY-0515 candidate earlier this year. Earlier this year ...

Roche Holding AG Akt-0.45% CHF234.65B ...

Dyne Therapeutics Inc.-5.60% $1.56B ...

After hours: February 7 at 6:12:20 PM EST Loading Chart for VERA ...

Note Includes index. "This book is intended to give the reader an insight into what it was like to be in the close-knit team that was the RNZAF Air Combat Force. Whether in the flying units based at ...

For more control, third-party tools like TranslucentTB and TaskbarTools let users make the taskbar fully transparent or adjust its transparency level. These apps are easy to use, lightweight, and ...